Literature DB >> 16944066

[Tako-Tsubo cardiomyopathy--a novel cardiac entity?].

Holger M Nef1, Helge Möllmann, Christian W Hamm, Albrecht Elsässer.   

Abstract

In recent years, a new cardiac syndrome with transient left ventricular dysfunction has been widely reported in Japan. This new entity has been referred to as "tako-tsubo cardiomyopathy" or "apical ballooning", named for the particular shape of the end-systolic left ventricle in ventriculography. This syndrome has also been reported to occur in the western population. The clinical characteristics of this phenomenon have been described as follows: (1) acute onset of reversible left ventricular apical wall motion abnormalities (ballooning) with chest pain, (2) electrocardiographic changes (i.e., ST elevation), (3) minimal myocardial enzymatic release, and (4) no significant stenosis on coronary angiography. Severe emotional or physical stress usually precedes this cardiomyopathy. A unifying mechanistic explanation responsible for this acute but rapidly reversible contractile dysfunction is still lacking. Several investigations suggested catecholamine-mediated cardiotoxicity or coronary artery vasospasm, microvascular injury, an impaired fatty acid metabolism, or transient obstruction of the left ventricular outflow. The optimal treatment of patients presenting with this syndrome may depend on the stage of condition, since various pathophysiological mechanisms underlie the final clinical picture.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16944066     DOI: 10.1007/s00059-006-2858-y

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  4 in total

1.  [Patient care in the acute phase of stress induced cardiomyopathy (Tako-Tsubo cardiomyopathy)--and thereafter?].

Authors:  V Kurowski; P W Radke; H Schunkert; C Burgdorf
Journal:  Herz       Date:  2010-06       Impact factor: 1.443

2.  [Historical and current pathophysiological concepts of stress (Tako-Tsubo) cardiomyopathy].

Authors:  S Szardien; H Möllmann; A Elsässer; C W Hamm; H M Nef
Journal:  Herz       Date:  2010-06       Impact factor: 1.443

3.  Targeting of the Akt/PKB kinase to the actin skeleton.

Authors:  V Cenni; A Sirri; M Riccio; G Lattanzi; S Santi; A de Pol; N M Maraldi; S Marmiroli
Journal:  Cell Mol Life Sci       Date:  2003-12       Impact factor: 9.261

Review 4.  Advances in clinical applications of cardiovascular magnetic resonance imaging.

Authors:  W P Bandettini; A E Arai
Journal:  Heart       Date:  2008-01-20       Impact factor: 5.994

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.